workithealth.comHealthcare / Healthcare providers & servicesFounded: 2014Funding to Date: $108.14MM
Workit Health is a virtual addiction care business focused on aiding those struggling with opioid, stimulant and alcohol addictions. Workit clinitians can prescribe FDA-approved medications, and Workit users have access to community support during their recovery. Workit Health was founded in 2014 by Robin McIntosh and Lisa McLaughlin and is headquartered in Ann Arbor, MI.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/22/2021 | Series C | $88MM | $xx.xx | $506.42MM | 3l Capital, Bcbs Venture Fund, Cvs Health Ventures, Firstmark Capital, Insight Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,985,644
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
3l Capital, Bcbs Venture Fund, Cvs Health Ventures, Firstmark Capital, Insight Partners
|
||||||
12/15/2020 | Series B | $12MM | $xx.xx | $47.92MM | Firstmark Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,931,958
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Firstmark Capital
|
||||||
01/31/2019 | Series A-4 | $5MM | $xx.xx | $14.56MM | Blue Cross Blue Shield Venture Partners, Endeavor Catalyst, Invest Detroit, Lux Capital, Montage Ventures, Rre Ventures, Wakestream Ventures | |
Price per Share
$xx.xx
Shares Outstanding
8,155,139
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blue Cross Blue Shield Venture Partners, Endeavor Catalyst, Invest Detroit, Lux Capital, Montage Ventures, Rre Ventures, Wakestream Ventures
|
||||||
08/15/2016 | Series A-1 | $40,318.00 | $xx.xx | $11.55MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
180,503
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/15/2016 | Series A-2 | $1.23MM | $xx.xx | $11.55MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,437,931
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/15/2016 | Series A-3 | $1.88MM | $xx.xx | $11.55MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,478,372
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|